AzarGen And iBio Push On With Plant-Based Rituximab

Biosimilar Development Aimed Towards African Continent

 
• By Dean Rudge
  
Plants_Biochemistry
AzarGen and iBio signed a master joint development agreement two years ago • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products